Celgene
Latest round
- Series A
Last raised
- Feb 2007
Total raised
- $9M
Investors
- 4
About Celgene
Celgene is a biopharmaceutical company that specializes in developing therapies primarily for cancer and immune-related conditions. The company was founded by Haley Branch and is headquartered in Summit, New Jersey, US. In January 2019, Bristol-Myers Squibb Company agreed to acquire Celgene for USD 74 billion in a cash and stock transaction, which will enable Bristol-Myers Squibb to expand its operations. Celgene's products focus on oncology therapies, including Opdivo (nivolumab) and Yervoy (ipilimumab), enhancing the body's immune response against cancer. They also offer treatments for cardiovascular disease, such as Eliquis (apixaban), and autoimmune diseases with therapies like Orencia (abatacept).Celgene generates revenue through direct sales of its pharmaceutical products to healthcare providers and institutions globally.Celgene's future growth strategy involves leveraging the recent acquisition by Bristol-Myers Squibb to enhance its portfolio and expand into new markets. The acquisition, finalized on January 3, 2019, for USD 74 billion, is expected to support the development of new products in oncology and immunology. The company aims to target expansion into emerging markets in Asia and Europe by 2025, aligning its product development with unmet medical needs in these regions.
Who invested in Celgene
4 investors across 1 round
See all investors in Celgene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 15, 2007
Amount
$9M
Investors
Questions about Celgene
Who invested in Celgene?
Celgene has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Celgene raised?
Celgene has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Celgene last raise money?
Celgene's most recent round on record is a Series A, in Feb 2007.
What does Celgene do?
Celgene is a biopharmaceutical company that specializes in developing therapies primarily for cancer and immune-related conditions.
Where is Celgene headquartered?
Celgene is headquartered in Summit, US.
Which VCs invest in companies like Celgene?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Celgene's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Celgene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.